AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines

BACKGROUND: Small cell lung cancer (SCLC) is a neuroendocrine tumor with poor prognosis. Neuroendocrine tumors possess characteristics of both nerve cells and hormone‐secreting cells; therefore, targeting the neuronal properties of these tumors may lead to the development of new therapeutic options....

Descripción completa

Detalles Bibliográficos
Autores principales: Masumoto, Nami, Kato, Shingo, Aichi, Masahiro, Hasegawa, Sho, Sahara, Kota, Suyama, Kumiko, Sano, Akane, Miyazaki, Tomoyuki, Okudela, Koji, Kaneko, Takeshi, Takahashi, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569908/
https://www.ncbi.nlm.nih.gov/pubmed/37605807
http://dx.doi.org/10.1111/1759-7714.15075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569908/
https://www.ncbi.nlm.nih.gov/pubmed/37605807
http://dx.doi.org/10.1111/1759-7714.15075

Ejemplares similares